Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report ; volume:5 ; number:1 ; day:7 ; month:7 ; year:2011 ; pages:1-6 ; date:12.2011
Journal of medical case reports ; 5, Heft 1 (7.7.2011), 1-6, 12.2011
- Urheber
-
Perazzi, Beatriz
- Beteiligte Personen und Organisationen
-
Bello, Natalia
Mollerach, Marta
Vay, Carlos
Lasala, María Beatriz
Famiglietti, Angela
SpringerLink (Online service)
- DOI
-
10.1186/1752-1947-5-292
- URN
-
urn:nbn:de:1111-2016071020390
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
01.01.1970, 01:00 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Perazzi, Beatriz
- Bello, Natalia
- Mollerach, Marta
- Vay, Carlos
- Lasala, María Beatriz
- Famiglietti, Angela
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erratum to Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
In vitro transfer of methicillin resistance determinants mecA from methicillin resistant Staphylococcus aureus (MRSA) to methicillin susceptible Staphylococcus aureus (MSSA)
Vancomycin‐Loaded Microneedle Arrays against Methicillin‐Resistant Staphylococcus Aureus Skin Infections
Interventions to treat methicillin-susceptible Staphylococcus aureus bacteremia: many methodological concerns
Resistenzverhalten Methicillin-resistenter Staphylococcus aureus (MRSA) gegenüber Vancomycin, Teicoplanin und Quinupristin-Dalfopristin
Vancomycin creep and daptomycin minimum inhibitory concentration in methicillin-resistant staphylococcus aureus
Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
Erratum to Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
In vitro transfer of methicillin resistance determinants mecA from methicillin resistant Staphylococcus aureus (MRSA) to methicillin susceptible Staphylococcus aureus (MSSA)
Vancomycin‐Loaded Microneedle Arrays against Methicillin‐Resistant Staphylococcus Aureus Skin Infections
Interventions to treat methicillin-susceptible Staphylococcus aureus bacteremia: many methodological concerns
Resistenzverhalten Methicillin-resistenter Staphylococcus aureus (MRSA) gegenüber Vancomycin, Teicoplanin und Quinupristin-Dalfopristin
Vancomycin creep and daptomycin minimum inhibitory concentration in methicillin-resistant staphylococcus aureus
Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
Erratum to Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
In vitro transfer of methicillin resistance determinants mecA from methicillin resistant Staphylococcus aureus (MRSA) to methicillin susceptible Staphylococcus aureus (MSSA)
Vancomycin‐Loaded Microneedle Arrays against Methicillin‐Resistant Staphylococcus Aureus Skin Infections
Interventions to treat methicillin-susceptible Staphylococcus aureus bacteremia: many methodological concerns
Resistenzverhalten Methicillin-resistenter Staphylococcus aureus (MRSA) gegenüber Vancomycin, Teicoplanin und Quinupristin-Dalfopristin
Vancomycin creep and daptomycin minimum inhibitory concentration in methicillin-resistant staphylococcus aureus